Rx patent monopoly and Lizzo TM win

Please join us Monday, March 6, 2023 where we will discuss Rx patent monopoly issues and Lizzo's TM win.  Specific case discussions will include: AbbVie Rx Patent Monopoly Strategy Against Biosimilars - AbbVie makes Humera for arthritis and extended its monopoly for 7 years past the 2016 expiration date of its basic patent on the [...]

By |2023-11-09T13:31:44-08:00March 2nd, 2023|Antitrust, FDA, Patent, Trademark, TTAB, monopoly|0 Comments
Go to Top